Showing 1641-1650 of 1841 results for "".
- Sight Sciences Appoints Erica Rogers to its Board of Directorshttps://modernod.com/news/sight-sciences-appoints-erica-rogers-to-its-board-of-directors/2477149/Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepreneur in the medical device industry. She most recently led Silk Road Medical through FDA approval of
- Fight For Sight and Prevent Blindness Announce Call for Entries for the 2020 Joanne Angle Public Health Awardhttps://modernod.com/news/fight-for-sight-and-prevent-blindness-announce-call-for-entries-for-the-2020-joanne-angle-public-health-award/2476933/National non-profit organizations Fight for Sight and Prevent Blindness are announcing a call for applications for the Joanne Angle Public Health Award, a $25,000 grant to support a public health research project seeking to put an end to unnecessary vision loss. The award was named for Ms
- Foundation Fighting Blindness Appoints Judy Taylor Vice President, Developmenthttps://modernod.com/news/foundation-fighting-blindness-appoints-judy-taylor-vice-president-development/2476733/The Foundation Fighting Blindness has announced that it has appointed Judy Taylor as vice president, development. In her new role, Ms. Taylor will be responsible and accountable for the strategic direction, planning and oversight of major gifts and planned giving function for the foundation.
- Allegro Ophthalmics Appoints Marc Carlson and Rebecca Colbert to Board of Directorshttps://modernod.com/news/allegro-ophthalmics-appoints-marc-carlson-and-rebecca-colbert-to-board-of-directors/2476454/Allegro Ophthalmics announced that two new independent members—Marc Carlson and Rebecca Colbert—have been appointed to the company’s Board of Directors with Ms. Colbert serving as Chairperson of the Board’s Audit Committee. Bringing extensive executive level commercial and financial leadership ex
- Lilliana Vazquez to Moderate Vision Expo’s EYE2EYE Series with Commonhttps://modernod.com/news/lilliana-vazquez-to-moderate-vision-expos-eye2eye-series-with-common/2476392/Vision Expo has announced Lilliana Vazquez will moderate its inaugural EYE2EYE series with award-winning artist Common. Ms. Vazquez is a multi-media personality that has acted as a host, influencer, style advisor and producer for the biggest names in entertainment, including working as a contribu
- Former P&G And Cincinnati Children’s Executive Katherine Overbey Joins OneSight As President And Executive Directorhttps://modernod.com/news/former-pg-and-cincinnati-childrens-executive-katherine-overbey-joins-onesight-as-president-and-executive-director/2480057/Global vision care nonprofit OneSight announced that Katherine “K-T” Overbey will be joining the organization as President and Executive Director. Ms. Overbey brings a distinct blend of blue-chip corporate and nonprofit experience in both developed and emerging markets, as well as a s
- SECO International Names Dr. R. Max Raynor as 2021 Presidenthttps://modernod.com/news/seco-international-names-dr-r-max-raynor-as-2021-president/2477497/SECO International has named R. Max Raynor, OD, as the next president. His term began on March 7, 2020, and will last through February 28, 2021. Dr. Raynor officially accepted the honor during the House of Delegates meeting held on Saturday, March 7 at SECO 20/20. “Dr. Raynor has dedicated
- Y.ora Vision and Eyexora Global Partner with SERI to Advance New MIGS Platform for Glaucomahttps://modernod.com/news/yora-vision-and-eyexora-global-partner-with-seri-to-advance-new-migs-platform-for-glaucoma/2484184/Y.ora Vision, a newly formed ophthalmic medical device company, announced the signing of a licensing agreement between the Singapore Eye Research Institute (SERI) and Eyexora Global to advance a next-generation minimally invasive surgical device for the treatment o
- FDA Officially Shifts to One-Trial Standard for New Drug Approvalshttps://modernod.com/news/fda-officially-shifts-to-one-trial-standard-for-new-drug-approvals/2485753/The FDA has announced a major change to its regulatory framework, formally establishing that a single well-designed pivotal clinical trial will be the new default basis for most drug and therapeutic approvals—replacing the long-standing expectation that two indepen
- Reciprocal Tariffs Take Effect: What Eye Care Professionals Need to Knowhttps://modernod.com/news/reciprocal-tariffs-take-effect-august-7-what-eye-care-professionals-need-to-know/2482916/Eye care professionals and optical businesses across the US are bracing for major changes as the White House prepares to implement new reciprocal tariffs on imported goods from key trade partners beginning August 7, 2025. The tarriffs come following a temp